Literature DB >> 30372385

Genetic Predisposition to Renal Cell Carcinoma: Implications for Counseling, Testing, Screening, and Management.

Brian Shuch1, Jin Zhang1.   

Abstract

In many individuals with renal cell carcinoma (RCC), a hereditary cause may have contributed to cancer development. Various risk factors can be suggestive of a genetic contribution, including early disease onset, multifocal or bilateral tumors, family history of RCC, and personal/family history of other benign or malignant tumors. Genetic counseling and understanding of the entire family tree are the first steps in evaluation and will determine if the patient should proceed with testing. Methods of testing have changed to next-generation sequencing, which allows multiple genes to be evaluated together. The results of testing have significant implications for the individual and his or her family members. Screening of the kidney and at-risk organs ensues, with most algorithms focused on early diagnosis and intervention to limit morbidity and mortality of disease manifestations. A comprehensive clinical program that can offer multidisciplinary care is useful for several complex cancer syndromes. Management of localized and advanced hereditary kidney cancers may differ from the sporadic forms of RCC. Knowledge of the genetics can have significant management implications and if necessary genetic evaluation can be expedited to allow treatment decisions.

Entities:  

Year:  2018        PMID: 30372385     DOI: 10.1200/JCO.2018.79.2523

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  11 in total

1.  Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.

Authors:  Maria I Carlo; A Ari Hakimi; Grant D Stewart; Gennady Bratslavsky; James Brugarolas; Ying-Bei Chen; W Marston Linehan; Eamonn R Maher; Maria J Merino; Kenneth Offit; Victor E Reuter; Brian Shuch; Jonathan A Coleman
Journal:  Eur Urol       Date:  2019-07-18       Impact factor: 20.096

2.  Progress in Kidney Cancer Outcomes Through Collaboration, Innovation, and Discovery.

Authors:  David F McDermott; Michael Carducci
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

3.  CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.

Authors:  Zaosong Zheng; Zhiliang Chen; Qiyu Zhong; Dingjun Zhu; Yingwei Xie; Wentai Shangguan; Wenlian Xie
Journal:  Cancer Sci       Date:  2021-02-10       Impact factor: 6.716

4.  Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study.

Authors:  Zhixian Wang; Yisheng Yin; Jing Wang; Yunpeng Zhu; Xing Li; Xiaoyong Zeng
Journal:  Front Oncol       Date:  2021-07-30       Impact factor: 6.244

5.  Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma.

Authors:  Wen Kong; Tongtong Yang; Xiaodong Wen; Zhongyi Mu; Cheng Zhao; Sujun Han; Jing Tian; Xinhao Zhang; Tao Zhou; Yanrui Zhang; Feng Lou; Shanbo Cao; Huina Wang; Jin Zhang
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

6.  Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives.

Authors:  Tavares Catarina; Maria Sofia Quental; José Ricardo Brandão; Miguel Silva-Ramos
Journal:  J Kidney Cancer VHL       Date:  2022-05-26

7.  Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.

Authors:  Gennady Bratslavsky; Neil Mendhiratta; Michael Daneshvar; James Brugarolas; Mark W Ball; Adam Metwalli; Katherine L Nathanson; Phillip M Pierorazio; Ronald S Boris; Eric A Singer; Maria I Carlo; Mary B Daly; Elizabeth P Henske; Colette Hyatt; Lindsay Middleton; Gloria Morris; Anhyo Jeong; Vivek Narayan; W Kimryn Rathmell; Ulka Vaishampayan; Bruce H Lee; Dena Battle; Michael J Hall; Khaled Hafez; Michael A S Jewett; Christina Karamboulas; Sumanta K Pal; A Ari Hakimi; Alexander Kutikov; Othon Iliopoulos; W Marston Linehan; Eric Jonasch; Ramaprasad Srinivasan; Brian Shuch
Journal:  Cancer       Date:  2021-08-03       Impact factor: 6.860

8.  SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling.

Authors:  Jiangyi Wang; Yun Zou; Bowen Du; Wenzhi Li; Guopeng Yu; Long Li; Lin Zhou; Xin Gu; Shangqing Song; Yushan Liu; Wenquan Zhou; Bin Xu; Zhong Wang
Journal:  Cell Death Dis       Date:  2021-07-03       Impact factor: 8.469

Review 9.  Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.

Authors:  Philip S Smith; James Whitworth; Hannah West; Jacqueline Cook; Carol Gardiner; Derek H K Lim; Patrick J Morrison; R Gordon Hislop; Emily Murray; Marc Tischkowitz; Anne Y Warren; Emma R Woodward; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2020-02-05       Impact factor: 5.006

10.  Ferroptosis resistance determines high susceptibility of murine A/J strain to iron-induced renal carcinogenesis.

Authors:  Zhen Cheng; Shinya Akatsuka; Guang Hua Li; Kiyoshi Mori; Takashi Takahashi; Shinya Toyokuni
Journal:  Cancer Sci       Date:  2021-11-23       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.